Nicholas J. Ollberding, PhD
- Member, Division of Biostatistics and Epidemiology
- Professor, UC Department of Pediatrics
About
Biography
I’m an epidemiologist with applied research interests in pediatric cardiology, nutrition, and the impact of the developing infant intestinal microbiome on growth and early development. My areas of methodical research interest include applying and developing analytical methods for microbial metagenomic next-generation sequence data, dietary assessment and analysis methodology, predictive modeling and causal inference.
My interest in research stems from a desire to improve the health outcomes of children. I strive for the thoughtful application of epidemiologic research methods and biostatistics to support evidence-based care.
I collaborate broadly as a quantitative methodologist in health sciences research and lead the Biostatistics, Epidemiology and Research Design (BERD) Core of the Center for Clinical & Translational Science & Training (CCTST), the Microbial Metagenomics Analysis Center, and the Biostatistics Service for the Heart Institute Research Core at Cincinnati Children’s. My current work is largely focused on supporting these core services.
I have been a researcher for over 15 years and began working at Cincinnati Children’s in 2014.
PhD: Columbia University, New York, 2009.
MPhil: Columbia University, New York, 2009.
MS: University of Cincinnati, Cincinnati, OH, 2008.
BS: Miami University, Oxford, OH, 2004.
Interests
Pediatric cardiology; microbial metagenomics
Interests
Application and development of analytical methods for microbial metagenomic next-generation sequence data; dietary assessment and analysis methodology; predictive modeling; causal inference
Research Areas
Publications
Biomarker-based acute kidney injury sub-phenotypes refine risk assessment in children undergoing cardiac surgery. Pediatric Nephrology. 2025; 40:523-531.
Left Atrial Phasic Function via Cardiac Magnetic Resonance Imaging in Patients with Duchenne Muscular Dystrophy. Pediatric Cardiology. 2025; 46:72-80.
Characteristics and outcomes of children ≤ 10 kg receiving continuous kidney replacement therapy: a WE-ROCK study. Pediatric Nephrology. 2025; 40:253-264.
1430: CONTINUOUS RENAL REPLACEMENT THERAPY IN CHILDREN AND YOUNG ADULTS WITH HEART DISEASE. Critical Care Medicine. 2025; 53.
Looking at the full picture, using topic modeling to observe microbiome communities associated with disease. 2024; 1:1-11.
Machine Learning-Based Prediction Model for ICU Mortality After Continuous Renal Replacement Therapy Initiation in Children. Critical Care Explorations. 2024; 6:e1188.
Impact of Functional Status at the Time of Transplant on Short-Term Pediatric Lung Transplant Outcomes in the USA. Lung: an international journal on lungs, airways and breathing. 2024; 202:775-783.
Prediction of cardiac surgery associated acute kidney injury using response to loop diuretic and urine neutrophil gelatinase associated lipocalin. Pediatric Nephrology. 2024; 39:3597-3606.
Abstract 4140698: CASE MANAGERS AND PEER SUPPORT GROUPS (CAMPS) FOR PROPHYLAXIS ADHERENCE IN RHEUMATIC HEART DISEASE. Circulation. 2024; 150:a4140698.
Characteristics and Outcomes of Children and Young Adults With Sepsis Requiring Continuous Renal Replacement Therapy: A Comparative Analysis From the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK). Critical Care Medicine. 2024; 52:1686-1699.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
